Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. AMAT
6. NRIX
7. SUNS
8. SPY
9. CRDO
10. OIG

Go back to Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results

Apellis Pharmaceuticals, Inc. (APLS) Misses Q1 EPS by 40c

May 7, 2025 7:08 AM EDT

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) reported Q1 EPS of ($0.74), $0.40 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $166.8 million versus the consensus estimate of $197.77 million.

For earnings history and earnings-related data on Apellis Pharmaceuticals, Inc. (APLS) click here.

... More